Capricor Therapeutics Inc (CAPR) support and resistance · $1.62B cap
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
This page maps Capricor Therapeutics Inc (CAPR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
CAPR currently screens at market cap $1.62B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CAPR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CAPR quote page for the session range and the stock page for the full model.
Not investment advice.